NasdaqGS - Nasdaq Real Time Price USD
Dyne Therapeutics, Inc. (DYN)
11.76
-0.58
(-4.70%)
At close: May 21 at 4:00:01 PM EDT
12.12
+0.36
+(3.06%)
After hours: May 21 at 7:39:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 3,116,296 | 8 |
| Sales | 405,819 | 14 |
| Net Shares Purchased (Sold) | 2,710,477 | 22 |
| Total Insider Shares Held | 784.3k | -- |
| % Net Shares Purchased (Sold) | -140.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| FRIEDL-NADERER JOHANNA Officer | Sale at price 12.12 per share. | Direct | 1,733 | Mar 13, 2025 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 11.38 per share. | Direct | 15,283 | Mar 11, 2025 |
| BESKROVNAYA OXANA Officer | Sale at price 11.38 per share. | Direct | 24,501 | Mar 11, 2025 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 11.83 per share. | Direct | 10,848 | Mar 5, 2025 |
| KERR DOUGLAS Officer | Sale at price 11.83 per share. | Direct | 15,888 | Mar 5, 2025 |
| BESKROVNAYA OXANA Officer | Sale at price 11.83 per share. | Direct | 12,942 | Mar 5, 2025 |
| COX JOHN Chief Executive Officer | Sale at price 11.83 per share. | Direct | 48,042 | Mar 5, 2025 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 13.95 per share. | Direct | 34,708 | Feb 18, 2025 |
| BESKROVNAYA OXANA Officer | Sale at price 13.95 per share. | Direct | 36,242 | Feb 18, 2025 |
| RHODES JASON P Director | Stock Award(Grant) at price 13.50 per share. | Indirect | 14,999,998 | Jan 27, 2025 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 28.12 per share. | Direct | 40,915 | Dec 11, 2024 |
| BESKROVNAYA OXANA Officer | Sale at price 28.12 per share. | Direct | 65,632 | Dec 11, 2024 |
| KERSTEN DIRK Director | Sale at price 29.18 - 29.34 per share. | Indirect | 3,988,016 | Dec 9, 2024 |
| KERSTEN DIRK Director | Sale at price 29.05 - 29.39 per share. | Indirect | 4,079,361 | Dec 5, 2024 |
| SCALZO RICHARD WILLIAM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| KERR DOUGLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| BESKROVNAYA OXANA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| COX JOHN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| FRIEDL-NADERER JOHANNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 4, 2024 |
| KERSTEN DIRK Director | Sale at price 29.05 - 30.37 per share. | Indirect | 3,273,008 | Dec 3, 2024 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 28.20 per share. | Direct | 77,127 | Nov 18, 2024 |
| BESKROVNAYA OXANA Officer | Sale at price 28.20 per share. | Direct | 80,539 | Nov 18, 2024 |
| INCERTI CARLO Director | Sale at price 28.73 per share. | Direct | 474,045 | Nov 18, 2024 |
| INCERTI CARLO Director | Conversion of Exercise of derivative security at price 8.69 per share. | Direct | 143,385 | Nov 18, 2024 |
| RHODES JASON P Director | Sale at price 33.10 per share. | Indirect | 25,884 | Nov 14, 2024 |
| KERSTEN DIRK Director | Sale at price 32.82 - 35.24 per share. | Indirect | 673,748 | Nov 14, 2024 |
| KERSTEN DIRK Director | Sale at price 35.06 - 35.16 per share. | Indirect | 475,878 | Oct 21, 2024 |
| KERSTEN DIRK Director | Sale at price 35.17 - 35.35 per share. | Indirect | 1,294,437 | Oct 17, 2024 |
| KERSTEN DIRK Director | Sale at price 35.13 per share. | Indirect | 191,142 | Oct 3, 2024 |
| KERSTEN DIRK Director | Sale at price 35.16 - 35.38 per share. | Indirect | 1,057,460 | Oct 2, 2024 |
| KERSTEN DIRK Director | Sale at price 35.00 - 36.02 per share. | Indirect | 1,099,697 | Sep 30, 2024 |
| KERSTEN DIRK Director | Sale at price 35.06 - 35.29 per share. | Indirect | 127,102 | Sep 26, 2024 |
| KERSTEN DIRK Director | Sale at price 35.19 - 37.01 per share. | Indirect | 4,336,893 | Sep 23, 2024 |
| KERSTEN DIRK Director | Sale at price 35.03 - 36.41 per share. | Indirect | 2,902,720 | Sep 19, 2024 |
| HIGH SUSANNA GATTI Chief Operating Officer | Sale at price 34.41 per share. | Direct | 308,864 | Sep 18, 2024 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 34.55 per share. | Direct | 48,024 | Sep 18, 2024 |
| BESKROVNAYA OXANA Officer | Sale at price 34.55 per share. | Direct | 80,812 | Sep 18, 2024 |
| KERSTEN DIRK Director | Sale at price 35.04 - 35.13 per share. | Indirect | 161,198 | Sep 17, 2024 |
| HIGH SUSANNA GATTI Chief Operating Officer | Sale at price 31.89 per share. | Direct | 168,060 | Sep 11, 2024 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 31.89 per share. | Direct | 46,815 | Sep 11, 2024 |
| BESKROVNAYA OXANA Officer | Sale at price 31.89 per share. | Direct | 68,914 | Sep 11, 2024 |
| SCALZO RICHARD WILLIAM Officer | Sale at price 32.14 - 32.63 per share. | Direct | 4,052,851 | Sep 6, 2024 |
| SCALZO RICHARD WILLIAM Officer | Conversion of Exercise of derivative security at price 5.54 - 19.00 per share. | Direct | 1,463,376 | Sep 6, 2024 |
| KERSTEN DIRK Director | Sale at price 35.03 per share. | Indirect | 55,242 | Sep 5, 2024 |
| COX JOHN Chief Executive Officer | Purchase at price 32.57 - 33.09 per share. | Indirect | 1,057,216 | Sep 4, 2024 |
| KERR DOUGLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| FRIEDL-NADERER JOHANNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| KERSTEN DIRK Director | Sale at price 45.49 - 46.01 per share. | Indirect | 1,427,063 | Aug 30, 2024 |
| KERSTEN DIRK Director | Sale at price 44.41 - 45.81 per share. | Indirect | 6,045,783 | Aug 29, 2024 |
Related Tickers
RNA Avidity Biosciences, Inc.
30.62
-3.22%
SRRK Scholar Rock Holding Corporation
30.72
-2.60%
CNTA Centessa Pharmaceuticals plc
12.82
-2.88%
ETNB 89bio, Inc.
9.61
+6.42%
TRML Tourmaline Bio, Inc.
15.11
-6.73%
SION Sionna Therapeutics, Inc.
13.50
-3.64%
ELVN Enliven Therapeutics, Inc.
16.93
-2.59%
IDYA IDEAYA Biosciences, Inc.
19.15
-2.45%
IMVT Immunovant, Inc.
14.41
-3.93%
EWTX Edgewise Therapeutics, Inc.
14.59
-1.88%